NCT06924463
- Conditions
- Myosarcoma, Neoplasms, Neoplasms by Histologic Type, +4 more
- Locations
-
- Oscar Lambret Center Lille, Nord, France
Clinical trial condition
Rhabdomyosarcoma
Explore clinical trials studying Rhabdomyosarcoma. Study availability and eligibility vary by location and protocol.
187 public trials
36 recruiting studies
Rhabdomyosarcoma trial results
NCT06836492
- Conditions
- Myosarcoma, Neoplasms, Neoplasms by Histologic Type, +5 more
- Locations
-
- Suying Lu Guangzhou, Guangdong, China
NCT06816771
- Conditions
- Disease Attributes, Myosarcoma, Neoplasms, +9 more
- Locations
-
- No. 440 Jiyan Road, Jinan City, Shandong Province Jinan, Shandong, China
NCT06684327
- Conditions
- Adenocarcinoma, Carcinoma, Endocrine Gland Neoplasms, +27 more
- Locations
-
- Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China
NCT06456892
- Conditions
- Myosarcoma, Neoplasms, Neoplasms by Histologic Type, +5 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Recruiting
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
NCT04625907
- Conditions
- Myosarcoma, Neoplasms, Neoplasms by Histologic Type, +4 more
- Locations
-
- Queensland Children's Hospital Brisbane, Australia
- Chris O'brien Lifehouse Camperdown, Australia
- Monash Children's Hospital Clayton, Australia
- Peter Maccallum Cancer Centre Melbourne, Australia
Not yet recruiting
A Phase 1/2 Study of CBX-12 in Children, Adolescents, or Young Adults With Solid Tumors That Have Come Back After Treatment or Are Difficult to Treat
NCT07830667
- Conditions
- Myosarcoma, Neoplasms, Neoplasms by Histologic Type, +20 more
- Locations
-
Not specified
Not yet recruiting
Tumor-Lymph Node Mapping
NCT07054944
- Conditions
- Germ Cell Tumor, Myosarcoma, Neoplasms, +7 more
- Locations
-
- University of Rochester Medical Center Rochester, New York, United States
NCT07516353
- Conditions
- ALL, AML, Acute Lymphoblastic Leukemia ,Lymphomas, +32 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Not yet recruiting
Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors
NCT07444918
- Conditions
- Disease Attributes, Myosarcoma, Neoplasms, +13 more
- Locations
-
Not specified